Stocks and Investing Stocks and Investing
Thu, September 23, 2021
Wed, September 22, 2021

Difei Yang Maintained (BLUE) at Strong Buy with Decreased Target to $23 on, Sep 22nd, 2021


Published on 2024-10-27 17:58:09 - WOPRAI, Difei Yang
  Print publication without navigation


Difei Yang of Mizuho, Maintained "bluebird bio, Inc." (BLUE) at Strong Buy with Decreased Target from $29 to $23 on, Sep 22nd, 2021.

Difei has made no other calls on BLUE in the last 4 months.



There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, all agree with Difei's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • John Newman of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $20 on, Tuesday, August 10th, 2021
  • Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $23 on, Tuesday, August 10th, 2021
  • Yanan Zhu of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $25 on, Tuesday, August 10th, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $35 on, Friday, July 16th, 2021
  • Yun Zhong of "Berenberg" Downgraded from Strong Buy to Hold and Held Target at $35 on, Thursday, July 1st, 2021
Contributing Sources